New insights into the pathogenesis of fibromyalgia syndrome: Important role of peripheral and central pain mechanisms

Current Rheumatology Reviews

Volumn 3, Issue 2, 2007, Pages 113-121

  Staud, Roland ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Chronic pain; Fibromyalgia; Nociception; Temporal summation

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ARGIPRESSIN; CALCITONIN GENE RELATED PEPTIDE; CHOLINERGIC RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; NERVE GROWTH FACTOR; NEUROTRANSMITTER; SUBSTANCE P;

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; BACKACHE; CHRONIC PAIN; CIRCADIAN RHYTHM; CORTICOTROPIN RELEASE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; EXERCISE; FIBROMYALGIA; HEADACHE; HORMONE RELEASE; HUMAN; HYPERALGESIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERSTITIAL CYSTITIS; IRRITABLE COLON; LIGHT DARK CYCLE; MECHANICAL STRESS; MUSCLE BIOPSY; MUSCLE BLOOD FLOW; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE ISCHEMIA; MUSCLE MITOCHONDRION; MUSCLE TONE; MUSCULOSKELETAL PAIN; MYOFASCIAL PAIN; NECK PAIN; NEUROTRANSMISSION; NOCICEPTION; NOCICEPTIVE RECEPTOR; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SLEEP WAKING CYCLE; TISSUE INJURY; TRIGGER POINT; VASOSPASM; WHIPLASH INJURY;

EID: 34248636796     PISSN: 15733971     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339707780619377     Document Type: Review

References (143)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
2. Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R. Increased neural sympathetic activation in fibromyalgia syndrome. Ann N Y Acad Sci 2006; 1069: 109-17.
3. Crofford LJ. The relationship of fibromyalgia to neuropathic pain syndromes. J Rheumatol Suppl 2005; 75: 41-5.
4. Gerwin RD. A review of myofascial pain and fibromyalgia - factors that promote their persistence. Acupunct Med 2005; 23: 121-34.
5. Adler GK, Kinsley. BT, Hurwitz S, Mossey CJ, Goldenberg DL. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999; 106: 534-43.
6. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6 - A pilot study in fibromyalgia. Arthritis Rheum 2000; 43: 872-80.
7. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593-601.
8. Bradley LA, Alarcon GS, Sotolongo A, et al. Cerebrospinal fluid (CSF) levels of substance P (SP) are abnormal in patients with fibromyalgia (FM) regardless of traumatic or insidious pain onset. Arthritis Rheum 1998; 41: S256.
9. Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988; 32: 21-6.
10. Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand J Rheumatol 2000; 29: 8-12.
11. Vierck CJ, Jr. Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 2006; 124: 242-63.
12. Rachlin ES. Myofascial Pain and Fibromyalgia. In History and Physical examination for regional myofascial pain syndromes. Edited by Rachlin ES. St. Louis: Mosby; 1994: 159-172.
13. Simons DG, Travell JG, Simons LS, Cummings BD. Myofascial Pain and Dysfunction: The Trigger Point Manual. Upper Half of the Body, edn 2. New York: Lippincott; Williams & Wilkins; 1999.
14. Long SP, Kephart W. Myofascial Pain Syndrome. In The Management of Pain. Edited by Ashburn MA, Rice LJ. Philadelphia: Churchill Livingstone; 1998: 299-321.
15. Gerwin RD. Myofascial pain syndromes in the upper extremity. J Hand Ther 1997; 10: 130-6.
16. Han SC, Harrison P. Myofascial pain syndrome and trigger-point management. Reg Anesth 1997; 22: 89-101.
17. Chu J. Twitch response in myofascial trigger points. J Musculoskelet Pain 1998; 6: 99-116.
18. Skootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal medicine practice. West J Med 1989; 151: 157-60.
19. Gerwin RD. Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep 2001; 5: 412-20.
20. Simons DG, Mense S. Understanding and measurement of muscle tone as related to clinical muscle pain. Pain 1998; 75: 1-17.
21. Shah JP, Phillips TM, Danoff JV, Gerber LH. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol 2005; 99: 1977-84.
22. Borg-Stein J, Simons DG. Myofascial pain. Arch Phys Med Rehabil 2002; 83: S40-S47.
23. Maekawa K, Clark GT, Kuboki T. Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. J Pain 2002; 3: 251-60.
24. Reinohl J, Hoheisel U, Unger T, Mense S. Adenosine triphosphate as a stimulant for nociceptive and non-nociceptive muscle group IV receptors in the rat. Neurosci Lett 2003; 338: 25-8.
25. Hubbard DR, Berkoff GM. Myofascial trigger points show spontaneous needle EMG activity. Spine 1993; 18: 1803-7.
26. Hong CZ, Yu J. Spontaneous electrical activity of rabbit trigger spot after transection of spinal cord and peripheral nerve. J Musculoskel Pain 1998; 6: 45-58.
27. Simons DG, Hong CZ, Simons LS. Endplate potentials are common to midfiber myofacial trigger points. Am J Phys Med Rehabil 2002; 81: 212-22.
28. Windisch A, Reitinger A, Traxler H, et al. Morphology and histo-chemistry of myogelosis. Clin Anat 1999; 12: 266-71.
29. Simons DG, Stolov WC. Microscopic features and transient contraction of palpable bands in canine muscle. Am J Phys Med 1976; 55: 65-88.
30. Mense S, Simons DG. Muscle pain: Understanding its nature, diagnosis, and treatment. Philadelphia: Lippincott Williams and Wilkins; 2001.
31. Dimaur S, Andreu AL, Bruno C, Hadjigeorgiou GM. Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med 2002; 2:189-96.
32. Larsson R, Oberg PA, Larsson SE. Changes of trapezius muscle blood flow and electromyography in chronic neck pain due to trapezius myalgia. Pain 1999; 79: 45-50.
33. Mense S. The pathogenesis of muscle pain. Curr Pain Headache Rep 2003; 7: 419-25.
34. Sluka KA, Price MP, Breese NA, Stucky CL, Wemmie JA, Welsh MJ. Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 2003; 106: 229-39.
35. Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 1999; 26: 1564-9.
36. Lewin GR, Mendell LM. Nerve growth factor and nociception. Trends Neurosci 1993; 16: 353-9.
37. Petty BG, Cornblath DR, Adornato BT, et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994; 36: 244-6.
38. Fu KY, Light AR, Maixner W. Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw. J Pain 2001; 2: 2-11.
39. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 2001; 40: 743-9.
40. Salemi S, Rethage J, Wollina U, et al. Detection of interleukin 1 beta (IL-1 ,beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 2003; 30: 146-50.
41. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 1991; 104: 765-7.
42. Staud R, Vierck CJ, Robinson ME, Price DD. Overall fibromyalgia pain is predicted by ratings of local pain and pain related negative affect: possible role of peripheral tissues. Rheumatology 2006; 45: 1409-15.
43. Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F. Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997; 40: 446-52.
44. Plesh O, Wolfe F, Lane N. The relationship between fibromyalgia and temporomandibular disorders: prevalence and symptom severity. J Rheumatol 1996; 23: 1948-52.
45. Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996; 53: 373-6.
46. Lapossy E, Maleitzke R, Hrycaj P, Mennet W, Muller W. The frequency of transition of chronic low back pain to fibromyalgia. Scand J Rheumatol 1995; 24: 29-33.
47. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology 2002; 122: 1140-56.
48. Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res 1997; 31: 125-31.
49. Walen HR, Oliver K, Groessl E, Cronan TA, Rodriguez VM. Traumatic events, health outcomes, and health care use in patients with fibromyalgia. J Musculoskelet Pain 2001; 9: 19-38.
50. Al Allaf AW, Dunbar KL, Hallum NS, Nosratzadeh B, Templeton KD, Pullar T. A case-control study examining the role of physical trauma in the onset of fibromyalgia syndrome. Rheumatology 2002; 41: 450-3.
51. Buskila D, Neumann L. The development of widespread pain after injuries. J Musculoskelet Pain 2002; 10: 261-7.
52. Wynne-Jones G, Jones GT, Wiles NJ, Silman AJ, Macfarlane GJ. Predicting new onset of widespread pain following a motor vehicle collision. J Rheumatol 2006; 33: 968-74.
53. Banic B, Petersen-Felix S, Andersen OK, et al. Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 2004; 107: 7-15.
54. Henriksson KG. Is fibromyalgia a distinct clinical entity? Pain mechanisms in fibromyalgia syndrome. A myologist's view. Best Pract Res Clin Rheumatol 1999; 13: 455-61.
55. Raphael KG, Marbach JJ, Klausner J. Myofascial face pain. Clinical characteristics of those with regional vs. widespread pain. J Am Dent Assoc 2000; 131: 161-71.
56. Henriksson KG. Fibromyalgia - From syndrome to disease. Overview of pathogenetic mechanisms. J Rehabilit Med 2003; 35: 89-94.
57. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993; 54: 241-89.
58. Mense S, Schmidt RF. Muscle pain: which receptors are responsible for the transmission of noxious stimuli? In Physiological aspects of clinical neurology. Edited by Rose, F.C. Oxford: Blackwell Scientific Publications 1976; 265-278.
59. Mense S. Considerations concerning the neurobiological basis of muscle pain. Can J Physiol Pharmacol 1991; 69: 610-6.
60. Lautenschlager J, Bruckle W, Schnorrenberger CC, Muller W. Measuring pressure pain of tendons and muscles in healthy probands and patients with generalized tendomyopathy (fibromyalgia syndrome). Z Rheumatol 1988; 47: 397-404.
61. Quimby LG, Block SR, Gratwick GM. Fibromyalgia: generalized pain intolerance and manifold symptom reporting. J Rheumatol 1988; 15: 1264-70.
62. Tunks E, Crook J, Norman G, Kalaher S. Tender points in fibromyalgia. Pain 1988; 34: 11-9.
63. Mikkelsson M, Latikka P, Kautiainen H, Isomeri R, Isomaki H. Muscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls. Arch Phys Mod Rehabil 1992; 73: 814-8.
64. Kosek E, Ekholm J, Hansson P. Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue. Pain 1995; 63: 335-9.
65. Bendtsen L, Norregaard J, Jensen R, Olesen J. Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 1997; 40: 98-102.
66. Vierck CJ, Cannon RL, Fry G, Maixner W, Whitsel BL. Characteristics of temporal summation of second pain sensations elicited by brief contact of glabrous skin by a preheated thermode. J Neurophysiol 1997; 78: 992-1002.
67. Hokfelt T, Zhang X, Su X, Wiesenfeld-Hallin Z. Central consequences of peripheral nerve damage. In Wall and Melzack's Textbook of Pain. Edited by McMahon S, Koltzenburg M. London: Elsevier; 2005: 947-959.
68. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91: 165-75.
69. Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck CJ. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 2003; 102: 87-95.
70. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003; 48: 1420-9.
71. Sorensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L. Hyperexcitability in fibromyalgia. J Rheumatol 1998; 25: 152-5.
72. Kosek E, Ekholm J, Hansson P. Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 1996; 64: 415-23.
73. Sluka KA, Kalra A, Moore SA. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 2001; 24: 37-46.
74. Bengtsson A, Henriksson KG, Larsson J. Muscle biopsy in primary fibromyalgia. Light-microscopical and histochemical findings. Scan J Rheumatol 1986; 15: 1-6.
75. Bartels EM, nneskiold-Samsoe B. Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet 1986; 1: 755-7.
76. Kalyan-Raman UP, Kalyan-Raman K, Yunus MB, Masi AT. Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histocheinical and ultrastructural study. J Rheumatol 1984; 11: 808-13.
77. Pongratz DE, Spath M. Morphologic aspects of fibromyalgia. Z Rheumatol 1998; 57: 47-51.
78. Drewes AM, Andreasen A, Schroder HD, Hogsaa B, Jennum P. Pathology of skeletal muscle in fibromyalgia: a histo-immuno-chemical and ultrastructural study. Br J Rheumatol 1993; 32: 479-83.
79. Fassbender HG, Wegner K. Morphology and pathogenesis of soft-tissue rheumatism. Z Rheumaforsch 1973; 32: 355-74.
80. Yunus MB, Kalyan-Raman UP, Masi AT, Aldag JC. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 1989; 16: 97-101.
81. Lindman R, Hagberg M, Bengtson A, Henriksson KG. Changes in trapezius muscle structure in fibromyalgia and chronic trapezius myalgia. J Musculoskelet Pain 1993; 1: 171-6.
82. Elvin A, Siosteen AK, Nilsson A, Kosek E. Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: A contrast media enhanced colour doppler study. Eur J Pain 2006; 10: 137-44.
83. Larsson SE, Alund M, Cai H, Oberg PA. Chronic pain after soft-tissue injury of the cervical spine: trapezius muscle blood flow and electromyograpby at static loads and fatigue. Pain 1994; 57: 173-80.
84. Bennett RM, Clark SR, Goldberg L, et al. Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum 1989; 32: 454-60.
85. Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986; 15: 165-73.
86. Strobel ES, Krapf M, Suckfull M, Bruckle W, Fleckenstein W, Muller W. Tissue oxygen measurement and 31P magnetic resonance spectroscopy in patients with muscle tension and fibromyalgia. Rheumatol Int 1997; 16: 175-80.
87. Bengtsson A, Henriksson KG, Larsson J. Muscle biopsy in primary fibromyalgia. Light-microscopical and histochemical findings. Scand J Rheumatol 1986; 15: 1-6.
88. Lindh M, Johansson G, Hedberg M, Henning GB, Grimby G. Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol 1995; 24: 34-7.
89. Lindman R, Hagberg M, Bengtsson A, Henriksson KG, Thornell LE. Capillary structure and mitochondrial volume density in the trapezius muscle of chronic trapezius myalgia, fibromyalgia and healthy subjects. J Musculoskelet Pain 1995; 3: 5-22.
90. Bengtsson A, Bengtsson M. Regional sympathetic blockade in primary fibromyalgia. Pain 1988; 33: 161-7.
91. Mense S, Stahnke M. Responses in muscle afferent fibres of slow conduction velocity to contractions and ischaemia in the cat. J Physiol 1983; 342: 383-97.: 383-97.
92. Qiao ZG, Vaeroy H, Morkrid L. Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 1991; 18: 1383-9.
93. Mengshoel AM, Vollestad NK, Forre O. Pain and fatigue induced by exercise in fibromyalgia patients and sedentary healthy subjects. Clin Exp Rheumatol 1995; 13: 477-82.
94. Vierck CJ, Staud R, Price DD, Cannon RL, Mauderli AP, Martin AD. The effect of maximal exercise on temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. J Pain 2001; 2: 334-44.
95. Bengtsson A. The muscle in fibromyalgia. Rheumatology 2002; 41: 721-4.
96. Granges G, Littlejohn GO. A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy and exercising subjects. J Rheumatol 1993; 20: 344-51.
97. Hansson P, Ekblom A, Lindblom U, Marchettini P. Does acute intraoral pain alter cutaneous sensibility? J Neurol Neurosurg Psychiatry 1988; 51: 1032-6.
98. Maixner W, Fillingim R, Booker D, Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 1995; 63: 341-51.
99. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Giani C, Zbinden AM, Radanov BP. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 2001; 17: 306-15.
100. Okifuji A, Turk DC. Stress and psychophysiological dysregulation in patients with Fibromyalgia syndrome. Appl Psychophysiol Bio-feedback 2002; 27: 129-41.
101. Bajaj P, Bajaj P, Madsen H, Moller M, Arendt-Nielsen L. Antenatal women with or without pelvic pain can be characterized by generalized or segmental hypoalgesia in late pregnancy. J Pain 2002; 3: 451-60.
102. Ushida T, Willis WD. Changes in dorsal horn neuronal responses in an experimental wrist contracture model. J Orthop Sci 2001; 6: 46-52.
103. Hoheisel U, Koch K, Mense S. Functional reorganization in the rat dorsal horn during an experimental myositis. Pain 1994; 59: 111-8.
104. Price DD, McHaffie JG, Larson MA. Spatial summation of heat-induced pain: influence of stimulus area and spatial separation of stimuli on perceived pain sensation intensity and unpleasantness. J Neurophysiol 1989; 62: 1270-9.
105. Staud R, Vierck CJ, Robinson ME, Price DD. Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 2004; 111: 342-50.
106. Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005; 114:295-302.
107. Herren-Gerber R, Weiss S, Arendt-Nielsen L, et al. Modulation of central hypersensitivity by nociceptive input in chronic pain after whiplash injury. Pain Medicine 2004; 5: 366-76.
108. Verne GN, Robinson ME, Vase L, Price DD. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003; 105: 223-30.
109. Neumann L, Zeldets V, Bolotin A, Buskila, D. Outcome of posttraumatic fibromyalgia: A 3-year follow-up of 78 cases of cervical spine injuries. Semin Arthritis Rheum 2003; 32: 320-5.
110. Bengtsson M, Bengtsson A, Jorfeldt L. Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain 1989; 39: 171-80.
111. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992; 51: 175-94.
112. Sorensen J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L, Bengtsson M. Fibromyalgia-are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 1997; 24: 1615-21.
113. Graven-Nielsen T, Aspegren KS, Henriksson KG, et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000; 85: 483-91.
114. Berglund B, Harju EL, Kosek E, Lindblom U. Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 2002; 96: 177-87.
115. Granot M, Buskila D, Granovsky Y, Sprecher E, Neumann L, Yarnitsky D. Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. Clin Neurophysiol 2001; 112: 1881-7.
116. Lorenz J, Grasedyck K, Bromm B. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996; 100: 165-8.
117. Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 1997; 13: 189-96.
118. Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992; 19: 846-50.
119. Granges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993; 36: 642-6.
120. Staud R, Price DD, Robinson ME, Mauderli AP, Vierck CJ. Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain 2004; 110: 689-96.
121. Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 2003; 7: 355-61.
122. Gracely RH, Petzke F, Wolf JK Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46: 1333-43.
123. Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004; 31: 364-78.
124. Kong J, White NS, Kwong KK, et al. Using fMRI to dissociate sensory encoding from cognitive evaluation of heat pain intensity. Hum Brain Mapp 2006; 27: 715-21.
125. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-52.
126. Czeisler CA, Klerman EB. Circadian and sleep-dependent regulation of hormone release in humans. Recent Prog Horm Res 1999; 54: 97-130.
127. Sarlis NJ, Chowdrey HS, Stephanou A, Lightman SL. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology 1992; 130: 1775-9.
128. Crofford LJ, Young EA, Engleberg NC, et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/ or chronic fatigue syndrome. Brain Behav Immun 2004; 18: 314-25.
129. Adler GK, Geenen R. Hypothalamic-pituitary-adrenal and autonomic nervous system functioning in fibromyalgia. Rheum Dis Clin North Am 2005; 31: 187-202, xi.
130. Ulas U, Unlu E, Hamamcioglu K, Odabasi Z, Cakci A, Vural O. Dysautonomia in fibromyalgia syndrome: sympathétic skin responses and RR interval analysis. Rheumatol Int 2006; 26: 383-7.
131. Jeschonneck M, Grohmann G, Hein G, Sprott H. Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology 2000; 39: 917-21.
132. Cohen H, Neumann L, Shore M, Amir M, Cassuto Y, Buskila D. Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability. Semin Arthritis Rheum 2000; 29: 217-27.
133. Bou-Holaigah I, Calkins H, Flynn JA, et al. Provocation of by-potension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 1997; 15: 239-46.
134. Furlan R, Colombo S, Perego F, et al. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol 2005; 32: 1787-93.
135. Vaeroy H, Qiao ZG, Morkrid L, Forre O. Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1989; 16: 1460-5.
136. Dinerman H, Goldenberg DL, Felson DT. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 1986; 13; 368-73.
137. Bennett RM, Clark SR, Campbell SM, et al. Symptoms of Raynaud's syndrome in patients with fibromyalgia. A study utilizing the Nielsen test, digital photoplethysmography, and measurements of platelet alpha 2-adrenergic receptors. Arthritis Rheum 1991; 34: 264-9.
138. Grassi W, De AR, Lapadula G, Leardini G, Scarpa R. Clinical diagnosis found in patients with Raynaud's phenomenon: a multicentre study. Rheumatol Int 1998; 18: 17-20.
139. Coffman JD, Cohen AS. Total and capillary fingertip blood flow in Raynaud's phenomenon. N Engl J Med 1971; 285: 259-63.
140. Jamieson GG, Ludbrook J, Wilson A. Cold hypersenstivity in Raynaud's phenomenon. Circulation 1971; 44: 254-64.
141. Lapossy E, Gasser P, Hrycaj P, Dubler B., Samborski W, Muller W. Cold-induced vasospasm. in patients with fibromyalgia and chronic low back pain in comparison to healthy subjects. Clin Rheumatol 1994; 13: 442-5.
142. Price DD, Bennett GJ, Rafii A. Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 1989; 36: 273-88.
143. Davis MC, Zautra AJ, Reich JW. Vulnerability to stress among women in chronic pain from fibromyalgia and osteoarthritis. Ann Behav Med 2001; 23: 215-26.